PainChek

PainChek Operating Cash Flow

The Operating Cash Flow of PainChek (PCK.AX) as of Nov 11, 2026 is -9.24 M AUD. In the previous year, Operating Cash Flow was -6.75 M AUD — a change of 36.79% (lower).

Operating Cash Flow

-9.24 MAUD

YoY

36.79%

Last updated:

Operating Cash Flow of PainChek is 2026 -9.24 M AUD. Operating Cash Flow of PainChek was 2025 -6.75 M AUD. It decreases by 36.79% lower compared to the previous year.

The PainChek Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2019
-3.07 M AUD
Jan 1, 2020
-1.89 M AUD
Jan 1, 2021
-4.12 M AUD
Jan 1, 2022
-7.00 M AUD
Jan 1, 2023
-6.32 M AUD
Jan 1, 2024
-7.13 M AUD
Jan 1, 2025
-6.75 M AUD
Jan 1, 2026
-9.24 M AUD
The PainChek Operating Cash Flow history
YEAROperating Cash FlowYoY
-9.24 MAUD+36.79%
-6.75 MAUD-5.25%
-7.13 MAUD+12.73%
-6.32 MAUD-9.64%
-7.00 MAUD+69.80%
-4.12 MAUD+118.43%
-1.89 MAUD-38.64%
-3.07 MAUD+5.56%
-2.91 MAUD+84.62%
-1.58 MAUD-35.43%
-2.44 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PainChek Stock analysis

What does PainChek do? PainChek Ltd. develops and commercializes mobile medical device applications, focusing on pain assessment for individuals unable to communicate with carers. The PainChek Universal combines the PainChek Application with the numerical rating scale (NRS), using artificial intelligence and facial recognition to detect pain in non-verbal patients. It provides a point-of-care solution that offers objectivity and consistency in pain assessments, supporting both non-verbal and self-reporting individuals through integrated tools. Healthcare providers and care facilities purchase PainChek Universal to enhance pain management protocols for patients with communication difficulties. The PainChek Application utilizes artificial intelligence and facial recognition technology to assess pain without relying on patient self-reporting, making it suitable for those with cognitive or physical impairments. PainChek Universal integrates the NRS for patients who can self-report, ensuring a comprehensive approach to pain evaluation across varying patient capabilities. This dual functionality allows healthcare professionals to apply consistent assessment standards regardless of a patient's ability to communicate. PainChek Ltd. generates revenue through the commercialization of its mobile medical device applications, specifically targeting healthcare providers and care facilities that require standardized pain assessment tools. The company’s products are designed to address the needs of patients who cannot communicate pain, thereby filling a critical gap in healthcare services. By offering a unified solution that combines AI-driven detection with traditional rating scales, PainChek Universal meets the demands of modern healthcare environments seeking objective and reliable pain management solutions. PainChek is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PainChek stock

Operating Cash Flow of PainChek is -9.24 M AUD in 2026.

Operating Cash Flow of PainChek changed from -6.75 M AUD to -9.24 M AUD, representing a 36.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow PainChek since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's PainChek historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — PainChek

All Key Metrics — PainChek